T/WFCMS SCM18-2017 International Clinical Practice Guidelines for Diabetes Mellitus
T/WFCMS SCM18-2017 International Clinical Practice Guidelines for Diabetes Mellitus
Basic Information
Scope
Scope: This document specifies the basic requirements for the diagnosis, differential diagnosis, and treatment of prediabetes and diabetes. This document is applicable to clinicians in traditional Chinese medicine endocrinology and integrated traditional and Western medicine endocrinology departments of all levels of medical institutions, serving as a basis for the diagnosis and treatment of prediabetes and diabetes. Western medicine endocrinology clinicians and TCM practitioners in other disciplines may also refer to the relevant content in this document. Main technical content: The purpose of formulating this document is to further standardize the clinical diagnosis and treatment of diabetes in traditional Chinese medicine, and to provide strategies and methods for the clinical practice of international TCM practitioners. This document is concise, practical, and highly actionable, meeting medical regulatory and legal requirements. It is guiding, universal, and referential, and can serve as an important reference for clinical practice, treatment guidelines, and quality evaluation. Since the implementation of the "Guidelines for the Prevention and Treatment of Diabetes in Traditional Chinese Medicine", the "Draft Standards for the Prevention and Treatment of Diabetes in Traditional Chinese Medicine", and the "Clinical Evidence-Based Practice Guidelines for Diabetes in Traditional Chinese Medicine (2016 Edition)", they have played a good guiding role in the diagnosis and treatment of diabetes. However, previous guidelines were limited by conditions, and the development process often used expert consensus as a recommendation standard, with low international recognition. With the rapid development of evidence-based medicine research in the field of traditional Chinese medicine, high-quality research results continue to emerge. On the basis of previous guidelines, this document conducts a rigorous quality evaluation of the treatment of prediabetes and diabetes based on